Long-term Prognosis and Valve Durability of TAVR
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorXijing Hospital
About this trial
This registry aims to evaluate the long-term prognosis and valve durability of transcatheter aortic valve replacement (TAVR) in a real-world setting. Baseline characteristics, procedural data, and clinical outcomes will be collected in a prospective and observational manner.
Eligibility criteria
Qualifiers
1. Patients with aortic stenosis or aortic valve insufficiency who were evaluated by the Heart team and underwent TAVR therapy
2. Patients who understand the purpose of the study, agree to participate in the trial and sign the informed consent form
Disqualifiers
1. Patients who cannot provide informed consent
2. Patients who are participating in other clinical trials
Trial design
Treatments tested in this trial
- Transcatheter aortic valve replacement
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov